Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway.

Abstract:

:Activation of the Wingless (Wnt)/ß-catenin signaling pathway contributes to prostate tumorigenesis and metastasis. Depending of the stage of prostate cancer development, current drug therapies are of limited efficiency, so that prevention with natural compounds appears as an attractive strategy especially due to the slow progressive development of prostate cancer. We report here that the chemopreventive agent curcumin from the rhizome of Curcuma longa was able to affect cell proliferation of androgen-dependent prostate cancer through the induction of cell cycle arrest in G2 and modulation of Wnt signaling. Curcumin decreases the level of Tcf-4, CBP and p300 proteins implicated in the Wnt transcriptional complex that leads to the decrease of ß-catenin/Tcf-4 transcriptional activity and of the expression of ß-catenin target genes (cyclin D1 and c-myc). Subsequent cell death induction is linked to autophagy. Interestingly, in androgen-independent prostate cancer cells, curcumin does not affect Wnt/ß-catenin transcriptional activity. Altogether our results suggest that curcumin is an interesting chemopreventive agent for early stage prostate cancer.

journal_name

Int J Oncol

authors

Teiten MH,Gaascht F,Cronauer M,Henry E,Dicato M,Diederich M

doi

10.3892/ijo.2011.905

subject

Has Abstract

pub_date

2011-03-01 00:00:00

pages

603-11

issue

3

eissn

1019-6439

issn

1791-2423

journal_volume

38

pub_type

杂志文章
  • Different rates of degradation of the proliferation-associated nuclear and nucleolar antigens during apoptosis of hl-60 cells induced by DNA topoisomerase inhibitors.

    abstract::One of the early events of apoptosis is proteolysis. The enzyme(s) involved in this event appear to be the serine protease(s), inasmuch as the reversible or irreversible inhibitors of serine proteases prevent DNA degradation and abrogate other signs of apoptosis in several cell systems (Gorczyca et al, Int J Oncol 1: ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.3.4.627

    authors: Gorczyca W,Ardelt B,Darzynkiewicz Z

    更新日期:1993-10-01 00:00:00

  • Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.

    abstract::Cadherins play a crucial role in epithelial morphogenesis and mediate intercellular adhesion. These receptors bind catenins and are involved in signal transduction pathways that regulate cell growth and apoptosis, and are frequently down-regulated in invasive and metastatic carcinomas. In order to assess the role of E...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Vizirianakis IS,Chen YQ,Kantak SS,Tsiftsoglou AS,Kramer RH

    更新日期:2002-07-01 00:00:00

  • COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.

    abstract::Tamoxifen (Tam), a selective estrogen receptor modulator, is in wide clinical use for the treatment and prevention of breast cancer. However, extended TAM administration for breast cancer induces increased VEGF levels in patients, promoting new blood vessel formation and thereby limiting its efficacy and highlighting ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2299

    authors: Du Y,Shi A,Han B,Li S,Wu D,Jia H,Zheng C,Ren L,Fan Z

    更新日期:2014-04-01 00:00:00

  • Mir-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2.

    abstract::MicroRNA (miRNA)-126 (miR-126) was reported to be downregulated and to act as a tumor suppressor in cancers of the lung, cervix, bladder and prostate. However, the functions of miR-126 in gastric cancer appear to be diverse and are largely unknown. MiR-126 was reported to act as a tumor suppressor by targeting the Crk...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2516

    authors: Liu LY,Wang W,Zhao LY,Guo B,Yang J,Zhao XG,Hou N,Ni L,Wang AY,Song TS,Huang C,Xu JR

    更新日期:2014-09-01 00:00:00

  • In vitro transformation of MCF-10A cells by sera harvested from heifers two months post-Zeranol implantation.

    abstract::Among many risk factors of breast cancer, estrogens and non-estrogenic endocrine disruptors are considered to play critical roles in human breast carcinogenesis. Zeranol (Z) is a non-steroidal agent with potent estrogenic activity and has been widely used as an FDA approved beef growth promoter in the US. Recently, co...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.941

    authors: Ye W,Xu P,Zhong S,Jen R,Threlfall WR,Frasure CV,Feng E,Li H,Lin SH,Liu JY,Lin YC

    更新日期:2011-04-01 00:00:00

  • Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow.

    abstract::Mxi1 protein is a basic helix-loop-helix, leucine zipper (bHLHZIP) transcriptional factor, which dimerizes with the Max protein. This heterodimer binds a specific DNA sequence (E-box) and suppresses transcription of target genes. On the other hand, c-Myc protein is also a bHLHZIP protein that dimerizes with Max, binds...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Kawamata N,Sugimoto KJ,Sakajiri S,Oshimi K,Koeffler HP

    更新日期:2005-05-01 00:00:00

  • Bortezomib induces G2-M arrest in human colon cancer cells through ROS-inducible phosphorylation of ATM-CHK1.

    abstract::Colorectal cancer (CRC) is one of the most common cancers; however, the development of drugs to treat the condition has reached a plateau. Bortezomib (PS-341, Velcade®) is a proteasome inhibitor approved for the treatment of hematological malignancies, including multiple myeloma. A few trials of bortezomib, alone or i...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2012.1448

    authors: Hong YS,Hong SW,Kim SM,Jin DH,Shin JS,Yoon DH,Kim KP,Lee JL,Heo DS,Lee JS,Kim TW

    更新日期:2012-07-01 00:00:00

  • Genetic alterations in metastatic renal cell carcinoma detected by comparative genomic hybridization: correlation with clinical and histological data.

    abstract::In order to optimize the management of patients with renal cell carcinoma (RCC) it is important to define the genetic risk for metastatic disease. In this study we performed comparative genomic hybridization (CGH) on metastatic tumors aiming at the identification of genetic alterations associated with metastatic disea...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.17.5.903

    authors: Junker K,Moravek P,Podhola M,Weirich G,Hindermann W,Janitzky V,Schubert J

    更新日期:2000-11-01 00:00:00

  • Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.

    abstract::Plakoglobin is a tumor suppressor gene in lung cancer; however, the mechanism by which it is downregulated in lung cancer is largely unknown. The aim of the present study was to investigate whether histone deacetylases (HDACs) regulate plakoglobin expression in lung cancer. The effects of overexpression or knockdown o...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4682

    authors: Sang Y,Sun L,Wu Y,Yuan W,Liu Y,Li SW

    更新日期:2019-03-01 00:00:00

  • Phase I clinical trial of peptide vaccination with URLC10 and VEGFR1 epitope peptides in patients with advanced gastric cancer.

    abstract::Peptide vaccine treatment has attracted attention in recent years as a new therapy option for chemotherapy‑resistant, advanced, unresectable cancer. The safety of peptide vaccination with HLA-A*2402-restricted URLC10-A24-177 and VEGFR1-A12-9 1084 epitope peptides (fixed 2-mg dose) was investigated in a phase I clinica...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2013.2242

    authors: Higashihara Y,Kato J,Nagahara A,Izumi K,Konishi M,Kodani T,Serizawa N,Osada T,Watanabe S

    更新日期:2014-03-01 00:00:00

  • Increased CDC20 expression is associated with development and progression of hepatocellular carcinoma.

    abstract::Cell division cycle 20 (CDC20) encodes a regulatory protein interacting with the anaphase-promoting complex/cyclosome (APC/C) in the cell cycle and plays important roles in tumorigenesis and progression of multiple tumors. The present study aimed to investigate the clinical significance of CDC20 in hepatocellular carc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2014.2559

    authors: Li J,Gao JZ,Du JL,Huang ZX,Wei LX

    更新日期:2014-10-01 00:00:00

  • In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination.

    abstract::Head and neck squamous cell carcinoma (HNSCC) and acute myeloid leukemia are the major causes of mortality and morbidity in Fanconi anemia (FA) patients. The objective of this study was to investigate the antineoplastic activity of PB, an antineoplastic nutrient mixture (containing quercetin, curcumin, green tea, cruc...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2015.2895

    authors: Roomi MW,Kalinovsky T,Roomi NW,Niedzwiecki A,Rath M

    更新日期:2015-05-01 00:00:00

  • Modulation of carcinogen-induced polyoma DNA-replication by organoselenium and organosulfur chemopreventive agents.

    abstract::Both chemical and physical carcinogens are potent inducers of asynchronous replication of various DNA tumor viruses. Employing H3 cells that carry an integrated copy of polyoma virus we have evaluated potential effects of known chemopreventive agents on carcinogen-induced polyoma DNA replication. The ability of well e...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2.3.413

    authors: Foiles P,Miglietta L,Dolan L,Elbayoumy K,Ronai Z

    更新日期:1993-03-01 00:00:00

  • Multipotent human breast stem cell line MCF1OAT.

    abstract::Human breast epithelial MCF10AT cells injected with Matrigel into the subcutis of nude/beige mice form simple ducts which, with time, resemble human proliferative breast disease and sporadically progress to carcinoma. Basement membrane was visualized with a silver stain and myoepithelial cells detected by their reacti...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.9.2.263

    authors: Tait L,Dawson P,Wolman S,Galea K,Miller F

    更新日期:1996-08-01 00:00:00

  • Reliability of a primary culture system to test cytotoxic drug activity in human-malignant melanoma.

    abstract::Optimal conditions have been defined to grow primary cultures of malignant melanoma suitable for in vitro pharmacological studies. A feasibility of primary cultures was observed in 60% of 62 clinical melanoma lymph node metastases. The neoplastic nature of the cells grown in culture, as assessed by the highly specific...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.1.6.619

    authors: Villa R,Zaffaroni N,Orlandi L,Costa A,Veronese S,Vaglini M,Silvestrini R

    更新日期:1992-11-01 00:00:00

  • Multiple sites of loss of heterozygosity on chromosome 8 in human breast cancer has differential correlation with clinical parameters.

    abstract::Recent studies have shown that chromosome 8p21-22 is the main site of frequent loss of heterozygosity (LOH) in breast cancers. However, the detailed molecular analysis of chromosome 8 so far in breast cancer has been variable. Most of the literature pertaining to LOH in breast cancer is mainly on short arm of chromoso...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.12.4.811

    authors: Dahiya R,Perinchery G,Deng G,Lee C

    更新日期:1998-04-01 00:00:00

  • Targeted delivery of anticancer drugs with intravenously administered magnetic liposomes in osteosarcoma-bearing hamsters.

    abstract::Although active targeting of anticancer drugs using magnetically responsive carriers is a very attractive treatment approach for solid tumors, successful results are limited. In particular, the therapeutic utility of intravenously administered magnetically responsive carriers has to date not been clearly established. ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.17.2.309

    authors: Kubo T,Sugita T,Shimose S,Nitta Y,Ikuta Y,Murakami T

    更新日期:2000-08-01 00:00:00

  • microRNA expression profile in undifferentiated gastric cancer.

    abstract::Prognosis of patients with undifferentiated gastric cancer is generally poor. The expression of various microRNAs (miRNAs) has not been comprehensively investigated in undifferentiated gastric cancer. Total RNA was extracted from the specimens of 42 undifferentiated gastric cancer tissues and paired normal gastric tis...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Katada T,Ishiguro H,Kuwabara Y,Kimura M,Mitui A,Mori Y,Ogawa R,Harata K,Fujii Y

    更新日期:2009-02-01 00:00:00

  • FOXO3a‑SIRT6 axis suppresses aerobic glycolysis in melanoma.

    abstract::Melanoma, the most aggressive human skin tumor, has a very short survival time, and there are currently no effective treatments. Alterations in cell metabolism, such as enhanced aerobic glycolysis, have been identified as hallmarks of cancer cells. In the present study, bioinformatics studies using online databases re...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2020.4964

    authors: Dong Z,Yang J,Li L,Tan L,Shi P,Zhang J,Zhong X,Ge L,Wu Z,Cui H

    更新日期:2020-03-01 00:00:00

  • Hypericin: a promising fluorescence marker for differentiating between glioblastoma and neurons in vitro.

    abstract::The naturally occurring photosensitizer, hypericin, with its high quantum yield of singlet oxygen photogeneration was studied for its ability to differentiate between glioblastoma cells and fetal rat neurons using fluorescence microscopy. Eight human glioma cell lines and twelve primary human glioma cell cultures were...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Ritz R,Müller M,Weller M,Dietz K,Kuci S,Roser F,Tatagiba M

    更新日期:2005-12-01 00:00:00

  • The anticancer agent pb-100 concentrates in the nucleus and nucleoli of human glioblastoma cells but does not enter normal astrocytes.

    abstract::Selectivity of the anticancer agent PB-100 for malignant cells, already demonstrated using cell growth and viability evaluation, is now confirmed by microscopic observations. PB-100 is easily detected inside cells by its yellow color under visible light and by its blue fluorescence; it may be measured in isolated nucl...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.7.1.81

    authors: Beljanski M,Crochet S

    更新日期:1995-07-01 00:00:00

  • Deleterious MnSOD signals lead to abnormal breast cell proliferation by radiation and estrogen exposure.

    abstract::Manganese superoxide dismutase (MnSOD) seems to have a pivotal role in maintaining the normal phenotype by suppressing cell growth through blocking the entrance of quiescent cells into the cell cycle. MnSOD protein expression has been shown to be dysregulated in malignant cells. A well-established experimental breast ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2011.978

    authors: Echiburú-Chau C,Roy D,Calaf GM

    更新日期:2011-06-01 00:00:00

  • Selective uveal melanoma inhibition with calcium channel blockade.

    abstract::Uveal malignant melanoma (UMM), the most common primary adult intraocular tumor with a marked metastatic potential, is genetically unique and has unfortunately had few treatment breakthroughs. In this study, we subjected a UMM cell line to high‑throughput library screening with 1,018 FDA‑approved compounds to identify...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4873

    authors: Shaughnessy M,Lamuraglia G,Klebanov N,Ji Z,Rajadurai A,Kumar R,Flaherty K,Tsao H

    更新日期:2019-11-01 00:00:00

  • Missense mutation of the hMSH6 and p53 genes in sporadic urothelial transitional cell carcinoma.

    abstract::Functional defects in DNA mismatch repair genes have been shown to be associated mainly with hereditary human malignancies. We examined genomic DNA from 88 sporadic transitional cell carcinomas (TCCs) of the urinary tract for mutations in hMSH6 gene by polymerase chain reaction and direct sequencing analysis. Mutation...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:

    authors: Furihata M,Shuin T,Takeuchi T,Sonobe H,Ohtsuki Y,Akiyama Y,Yuasa Y

    更新日期:2000-03-01 00:00:00

  • miRNA expression pattern associated with prognosis in elderly patients with advanced OPSC and OCC.

    abstract::The long-term survival for elderly patients with advanced ovarian papillary serous carcinoma (OPSC) does not exceed 30%, and the incidence and prognosis rise continuously after menopause. The aim of this study was to identify the differences in key miRNAs and their potential regulators through miRNA microarray analysi...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2013.1988

    authors: Zhao H,Ding Y,Tie B,Sun ZF,Jiang JY,Zhao J,Lin X,Cui S

    更新日期:2013-09-01 00:00:00

  • Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway.

    abstract::B7-H4 is a transmembrane protein which is a member of the B7 superfamily. It is overexpressed in various types of cancer, including gastric cancer. However, the effects of B7-H4 on the tumorigenicity of gastric cancer and the underlying mechanisms have not yet been fully explored. Thus, the aim of this study was to ex...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2018.4274

    authors: Zhou D,Zhou Y,Li C,Yang L

    更新日期:2018-04-01 00:00:00

  • Differential mechanisms of multidrug resistance are expressed during stepwise selection of KB-3-1 cells with adriamycin.

    abstract::A major limitation of cancer chemotherapy is development of resistance. In this study, we analyzed KB-3-1 cells and adriamycin-selected multidrug resistant sublines KB-A1 and KB-A10 cells for mechanisms of resistance. KB-A10 cells are 10-fold more resistant than KB-A1 cells but have lower P-glycoprotein. Of the known ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.11.5.1025

    authors: Villagra L,Darling A,Yassa D,Scheper R,Tritton T,Bhushan A

    更新日期:1997-11-01 00:00:00

  • The role of a Drosophila replication related element in dras2 oncogene regulation.

    abstract::The Drosophila ras2 and rop gene pair are governed by a common promoter. Characterisation of the Drosophila ras2/rop bidirectional promoter has revealed that a single major protein complex (M), composed of two subunits (factors A and B) interacts with two central promoter domains (regions A and B). To define the trans...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.7.5.1185

    authors: Lightfoot K,Tai A,Segev O

    更新日期:1995-11-01 00:00:00

  • Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression.

    abstract::Liver cancer is the fourth leading cause of cancer‑related mortality worldwide with limited therapeutic options. Thus, novel treatment strategies are urgently required. While the oncogenic kinase, proviral integration site for Moloney murine leukemia virus 2 (PIM2), has been shown to be overexpressed in liver cancer, ...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.2019.4936

    authors: Kronschnabl P,Grünweller A,Hartmann RK,Aigner A,Weirauch U

    更新日期:2020-02-01 00:00:00

  • Poor outcome in adolescents with high-risk Hodgkin lymphoma.

    abstract::This retrospective study looks at the differences between adolescents (15-19 years) and young adults (20-25 years), diagnosed with Hodgkin lymphoma and treated at the same adult institution. Outcome according to risk category was evaluated, and although there were no significant differences in the whole cohort, or low...

    journal_title:International journal of oncology

    pub_type: 杂志文章

    doi:10.3892/ijo.33.1.145

    authors: Herbertson RA,Evans LS,Hutchinson J,Horsman J,Hancock BW

    更新日期:2008-07-01 00:00:00